The latest study on Oncology Molecular Diagnostics Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Oncology Molecular Diagnostics Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Oncology Molecular Diagnostics and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Abbott Laboratories
Bayer Healthcare
Beckton Dickinson
Cepheid
Dako
Danaher
Gen Probe
Qiagen
Roche Diagnostics
Siemens
Sysmex
Oncology Molecular Diagnostics Market Analysis By Type Segment:
PCR
INAAT
DNA sequencing & NGS
In situ hybridization
DNA microarrays
Other
Oncology Molecular Diagnostics Market Analysis By Application Segment:
Infectious diseases
oncology
Genetic tests
Other
Oncology Molecular Diagnostics Market Analysis By Regions (Countries):
The Oncology Molecular Diagnostics Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Oncology Molecular Diagnostics Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Oncology Molecular Diagnostics Market:
Oncology Molecular Diagnostics market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Oncology Molecular Diagnostics Market status and future forecast.
To present the key Oncology Molecular Diagnostics Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oncology Molecular Diagnostics Market Size Growth Rate by Type (2016-2027)
1.4.2 PCR
1.4.3 INAAT
1.4.4 DNA sequencing & NGS
1.4.5 In situ hybridization
1.4.6 DNA microarrays
1.4.7 Other
1.5 Market by Application
1.5.1 Global Oncology Molecular Diagnostics Market Share by Application (2016-2027)
1.5.2 Infectious diseases
1.5.3 oncology
1.5.4 Genetic tests
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Oncology Molecular Diagnostics Market Size
2.2 Oncology Molecular Diagnostics Growth Trends by Regions
2.2.1 Oncology Molecular Diagnostics Market Size by Regions (2016-2027)
2.2.2 Oncology Molecular Diagnostics Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Oncology Molecular Diagnostics Market Size by Manufacturers
3.1.1 Global Oncology Molecular Diagnostics Revenue by Manufacturers (2020)
3.1.2 Global Oncology Molecular Diagnostics Revenue Market Share by Manufacturers (2020)
3.1.3 Global Oncology Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Oncology Molecular Diagnostics Key Players Head office and Area Served
3.3 Key Players Oncology Molecular Diagnostics Product/Solution/Service
3.4 Date of Enter into Oncology Molecular Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Oncology Molecular Diagnostics Market Size by Type (2016-2020)
4.2 Global Oncology Molecular Diagnostics Market Size by Application (2016-2020)
5 United States
5.1 United States Oncology Molecular Diagnostics Market Size (2016-2020)
5.2 Oncology Molecular Diagnostics Key Players in United States
5.3 United States Oncology Molecular Diagnostics Market Size by Type
5.4 United States Oncology Molecular Diagnostics Market Size by Application
6 Europe
6.1 Europe Oncology Molecular Diagnostics Market Size (2016-2020)
6.2 Oncology Molecular Diagnostics Key Players in Europe
6.3 Europe Oncology Molecular Diagnostics Market Size by Type
6.4 Europe Oncology Molecular Diagnostics Market Size by Application
7 China
7.1 China Oncology Molecular Diagnostics Market Size (2016-2020)
7.2 Oncology Molecular Diagnostics Key Players in China
7.3 China Oncology Molecular Diagnostics Market Size by Type
7.4 China Oncology Molecular Diagnostics Market Size by Application
8 Japan
8.1 Japan Oncology Molecular Diagnostics Market Size (2016-2020)
8.2 Oncology Molecular Diagnostics Key Players in Japan
8.3 Japan Oncology Molecular Diagnostics Market Size by Type
8.4 Japan Oncology Molecular Diagnostics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Oncology Molecular Diagnostics Market Size (2016-2020)
9.2 Oncology Molecular Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Oncology Molecular Diagnostics Market Size by Type
9.4 Southeast Asia Oncology Molecular Diagnostics Market Size by Application
10 India
10.1 India Oncology Molecular Diagnostics Market Size (2016-2020)
10.2 Oncology Molecular Diagnostics Key Players in India
10.3 India Oncology Molecular Diagnostics Market Size by Type
10.4 India Oncology Molecular Diagnostics Market Size by Application
11 Central & South America
11.1 Central & South America Oncology Molecular Diagnostics Market Size (2016-2020)
11.2 Oncology Molecular Diagnostics Key Players in Central & South America
11.3 Central & South America Oncology Molecular Diagnostics Market Size by Type
11.4 Central & South America Oncology Molecular Diagnostics Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oncology Molecular Diagnostics Introduction
12.1.4 Abbott Laboratories Revenue in Oncology Molecular Diagnostics Business (2020)
12.1.5 Abbott Laboratories Recent Development
12.2 Bayer Healthcare
12.2.1 Bayer Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oncology Molecular Diagnostics Introduction
12.2.4 Bayer Healthcare Revenue in Oncology Molecular Diagnostics Business (2020)
12.2.5 Bayer Healthcare Recent Development
12.3 Beckton Dickinson
12.3.1 Beckton Dickinson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oncology Molecular Diagnostics Introduction
12.3.4 Beckton Dickinson Revenue in Oncology Molecular Diagnostics Business (2020)
12.3.5 Beckton Dickinson Recent Development
12.4 Cepheid
12.4.1 Cepheid Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oncology Molecular Diagnostics Introduction
12.4.4 Cepheid Revenue in Oncology Molecular Diagnostics Business (2020)
12.4.5 Cepheid Recent Development
12.5 Dako
12.5.1 Dako Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oncology Molecular Diagnostics Introduction
12.5.4 Dako Revenue in Oncology Molecular Diagnostics Business (2020)
12.5.5 Dako Recent Development
12.6 Danaher
12.6.1 Danaher Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oncology Molecular Diagnostics Introduction
12.6.4 Danaher Revenue in Oncology Molecular Diagnostics Business (2020)
12.6.5 Danaher Recent Development
12.7 Gen Probe
12.7.1 Gen Probe Company Details
12.7.2 Company Description and Business Overview
12.7.3 Oncology Molecular Diagnostics Introduction
12.7.4 Gen Probe Revenue in Oncology Molecular Diagnostics Business (2020)
12.7.5 Gen Probe Recent Development
12.8 Qiagen
12.8.1 Qiagen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Oncology Molecular Diagnostics Introduction
12.8.4 Qiagen Revenue in Oncology Molecular Diagnostics Business (2020)
12.8.5 Qiagen Recent Development
12.9 Roche Diagnostics
12.9.1 Roche Diagnostics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Oncology Molecular Diagnostics Introduction
12.9.4 Roche Diagnostics Revenue in Oncology Molecular Diagnostics Business (2020)
12.9.5 Roche Diagnostics Recent Development
12.10 Siemens
12.10.1 Siemens Company Details
12.10.2 Company Description and Business Overview
12.10.3 Oncology Molecular Diagnostics Introduction
12.10.4 Siemens Revenue in Oncology Molecular Diagnostics Business (2020)
12.10.5 Siemens Recent Development
12.11 Sysmex
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Oncology Molecular Diagnostics Key Market Segments
Table Key Players Oncology Molecular Diagnostics Covered
Table Global Oncology Molecular Diagnostics Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Oncology Molecular Diagnostics Market Size Market Share by Type 2016-2027
Figure PCR Figures
Table Key Players of PCR
Figure INAAT Figures
Table Key Players of INAAT
Figure DNA sequencing & NGS Figures
Table Key Players of DNA sequencing & NGS
Figure In situ hybridization Figures
Table Key Players of In situ hybridization
Figure DNA microarrays Figures
Table Key Players of DNA microarrays
Figure Other Figures
Table Key Players of Other
Table Global Oncology Molecular Diagnostics Market Size Growth by Application 2016-2027 (Million US$)
Figure Infectious diseases Case Studies
Figure oncology Case Studies
Figure Genetic tests Case Studies
Figure Other Case Studies
Figure Oncology Molecular Diagnostics Report Years Considered
Table Global Oncology Molecular Diagnostics Market Size 2016-2027 (Million US$)
Figure Global Oncology Molecular Diagnostics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Oncology Molecular Diagnostics Market Size by Regions 2016-2027 (Million US$)
Table Global Oncology Molecular Diagnostics Market Size by Regions 2016-2020 (Million US$)
Table Global Oncology Molecular Diagnostics Market Share by Regions 2016-2020
Figure Global Oncology Molecular Diagnostics Market Share by Regions 2016-2020
Figure Global Oncology Molecular Diagnostics Market Share by Regions 2020
Table Market Top Trends
Table Global Oncology Molecular Diagnostics Revenue by Manufacturers (2020) (Million US$)
Table Global Oncology Molecular Diagnostics Market Share by Manufacturers (2020)
Figure Global Oncology Molecular Diagnostics Market Share by Manufacturers in 2020
Table Global Oncology Molecular Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Oncology Molecular Diagnostics Product/Solution/Service
Table Date of Enter into Oncology Molecular Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology Molecular Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Global Oncology Molecular Diagnostics Market Size Share by Type (2016-2020)
Figure Global Oncology Molecular Diagnostics Market Size Market Share by Type (2016-2020)
Table Global Oncology Molecular Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Global Oncology Molecular Diagnostics Market Size Share by Application (2016-2020)
Figure Global Oncology Molecular Diagnostics Market Size Market Share by Application (2016-2020)
Figure Global Oncology Molecular Diagnostics Revenue Market Share by Application in 2020
Figure United States Oncology Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table United States Key Players Oncology Molecular Diagnostics Revenue (2020) (Million US$)
Table United States Key Players Oncology Molecular Diagnostics Market Share (2020)
Table United States Oncology Molecular Diagnostics Market Size by Type (2016-2020) (Million US$)
Table United States Oncology Molecular Diagnostics Market Share by Type (2016-2020)
Table United States Oncology Molecular Diagnostics Market Size by Application (2016-2020) (Million US$)
Table United States Oncology Molecular Diagnostics Market Share by Application (2016-2020)
Figure Europe Oncology Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table Europe Key Players Oncology Molecular Diagnostics Revenue (2020) (Million US$)
Table Europe Key Players Oncology Molecular Diagnostics Market Share (2020)
Table Europe Oncology Molecular Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Europe Oncology Molecular Diagnostics Market Share by Type (2016-2020)
Table Europe Oncology Molecular Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Europe Oncology Molecular Diagnostics Market Share by Application (2016-2020)
Figure China Oncology Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table China Key Players Oncology Molecular Diagnostics Revenue (2020) (Million US$)
Table China Key Players Oncology Molecular Diagnostics Market Share (2020)
Table China Oncology Molecular Diagnostics Market Size by Type (2016-2020) (Million US$)
Table China Oncology Molecular Diagnostics Market Share by Type (2016-2020)
Table China Oncology Molecular Diagnostics Market Size by Application (2016-2020) (Million US$)
Table China Oncology Molecular Diagnostics Market Share by Application (2016-2020)
Figure Japan Oncology Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table Japan Key Players Oncology Molecular Diagnostics Revenue (2020) (Million US$)
Table Japan Key Players Oncology Molecular Diagnostics Market Share (2020)
Table Japan Oncology Molecular Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Japan Oncology Molecular Diagnostics Market Share by Type (2016-2020)
Table Japan Oncology Molecular Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Japan Oncology Molecular Diagnostics Market Share by Application (2016-2020)
Figure Southeast Asia Oncology Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Oncology Molecular Diagnostics Revenue (2020) (Million US$)
Table Southeast Asia Key Players Oncology Molecular Diagnostics Market Share (2020)
Table Southeast Asia Oncology Molecular Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Oncology Molecular Diagnostics Market Share by Type (2016-2020)
Table Southeast Asia Oncology Molecular Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Oncology Molecular Diagnostics Market Share by Application (2016-2020)
Figure India Oncology Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table India Key Players Oncology Molecular Diagnostics Revenue (2020) (Million US$)
Table India Key Players Oncology Molecular Diagnostics Market Share (2020)
Table India Oncology Molecular Diagnostics Market Size by Type (2016-2020) (Million US$)
Table India Oncology Molecular Diagnostics Market Share by Type (2016-2020)
Table India Oncology Molecular Diagnostics Market Size by Application (2016-2020) (Million US$)
Table India Oncology Molecular Diagnostics Market Share by Application (2016-2020)
Figure Central & South America Oncology Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Oncology Molecular Diagnostics Revenue (2020) (Million US$)
Table Central & South America Key Players Oncology Molecular Diagnostics Market Share (2020)
Table Central & South America Oncology Molecular Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Central & South America Oncology Molecular Diagnostics Market Share by Type (2016-2020)
Table Central & South America Oncology Molecular Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Central & South America Oncology Molecular Diagnostics Market Share by Application (2016-2020)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Oncology Molecular Diagnostics Business (2020) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Oncology Molecular Diagnostics Business (2020)
Table Abbott Laboratories Recent Development
Table Bayer Healthcare Company Details
Table Bayer Healthcare Revenue in Oncology Molecular Diagnostics Business (2020)(Million US$)
Figure Bayer Healthcare Revenue Growth Rate in Oncology Molecular Diagnostics Business (2020)
Table Bayer Healthcare Recent Development
Table Beckton Dickinson Company Details
Table Beckton Dickinson Revenue in Oncology Molecular Diagnostics Business (2020)(Million US$)
Figure Beckton Dickinson Revenue Growth Rate in Oncology Molecular Diagnostics Business (2020)
Table Beckton Dickinson Recent Development
Table Cepheid Company Details
Table Cepheid Revenue in Oncology Molecular Diagnostics Business (2020)(Million US$)
Figure Cepheid Revenue Growth Rate in Oncology Molecular Diagnostics Business (2020)
Table Cepheid Recent Development
Table Dako Company Details
Table Dako Revenue in Oncology Molecular Diagnostics Business (2020)(Million US$)
Figure Dako Revenue Growth Rate in Oncology Molecular Diagnostics Business (2020)
Table Dako Recent Development
Table Danaher Company Details
Table Danaher Revenue in Oncology Molecular Diagnostics Business (2020)(Million US$)
Figure Danaher Revenue Growth Rate in Oncology Molecular Diagnostics Business (2020)
Table Danaher Recent Development
Table Gen Probe Company Details
Table Gen Probe Revenue in Oncology Molecular Diagnostics Business (2020)(Million US$)
Figure Gen Probe Revenue Growth Rate in Oncology Molecular Diagnostics Business (2020)
Table Gen Probe Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Oncology Molecular Diagnostics Business (2020)(Million US$)
Figure Qiagen Revenue Growth Rate in Oncology Molecular Diagnostics Business (2020)
Table Qiagen Recent Development
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Oncology Molecular Diagnostics Business (2020)(Million US$)
Figure Roche Diagnostics Revenue Growth Rate in Oncology Molecular Diagnostics Business (2020)
Table Roche Diagnostics Recent Development
Table Siemens Company Details
Table Siemens Revenue in Oncology Molecular Diagnostics Business (2020)(Million US$)
Figure Siemens Revenue Growth Rate in Oncology Molecular Diagnostics Business (2020)
Table Siemens Recent Development
Table Sysmex Company Details
Table Global Oncology Molecular Diagnostics Market Size by Regions (Million US$) 2021-2027
Figure Global Oncology Molecular Diagnostics Market Size Share by Regions (2021-2027)
Figure Global Oncology Molecular Diagnostics Market Size Share by Regions in 2027
Figure United States Oncology Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Oncology Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure China Oncology Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Oncology Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Oncology Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure India Oncology Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Oncology Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Table Global Oncology Molecular Diagnostics Market Size by Product (2021-2027) (Million US$)
Figure Global Oncology Molecular Diagnostics Market Size by Product (2021-2027)
Figure Global Oncology Molecular Diagnostics Market Size by Product in 2027
Table Global Oncology Molecular Diagnostics Market Size by Application (2021-2027) (Million US$)
Figure Global Oncology Molecular Diagnostics Market Size by Application (2021-2027)
Figure Global Oncology Molecular Diagnostics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources